AHA Letter on Drug Price Transparency Bill

AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.

Letter: AHA Expresses Support for the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113)

Drug Price Transparency

Legislation and Legislative Advocacy